Is Ranbaxy an avoid given the US FDA extending the consent decree?

Click on to know Kunal Bothra's view, Technical Analyst at LKP Securities

Image
Jinsy Mathew Mumbai
Last Updated : Sep 17 2013 | 10:51 AM IST
Smartinvestor : What is your outlook on market and what are the key levels to watch out for on Nifty ?

Kunal Bothra : I think its a bit of a cautious approach for the markets, after yesterday's correction from day's high. I think that we could see a trading range for today as well. 5780 and 5850 are the key intraday levels to watch on Nifty spot levels.

Smartinvestor : What are your top picks from the banking names? And what are the levels?

Also Read

Kunal Bothra : AXISBANK is forming a double top formation. I think below 1050 one could look at a trading opportunity of shorting for a target of 1020-1025 and stop loss at 1065.

Smartinvestor : Is Ranbaxy an avoid given the US FDA extending the consent decree? What do the charts suggest?

Click here for the full transcript


*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Sep 17 2013 | 10:43 AM IST

Next Story